Adherium’s Directors Purchase Approximately 1.4 Million Shares on the Open Market

Adherium’s Directors Purchase Approximately 1.4 Million Shares on the Open Market

12 Mar 2018

SAN MATEO, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced that members of its Board of Directors recently purchased approximately 1.4 million shares on the open market. The timing of these purchases complied with the Company’s “blackout period” policy that required directors and employees to wait seven days following public disclosure of Adherium’s first half 2018 financial results.

“I’m delighted to see this level of support from our Board members. Their personal investment at this time demonstrates a commitment to the Company, as well as confidence in our strategy,” said Arik Anderson, CEO. “We had a great start to fiscal 2018, with first half results that included a 92% increase in revenue and a 63% increase in delivered devices over the comparable period in 2017, demonstrating the meaningful traction we are gaining.” 

Click here to view the full press release.